A patient reported to procept biorobotics corporation (procept) having a procedure in (b)(6) 2021 and the following day having emergency surgery and being drained fluid from the abdomen.The patient reported experiencing incontinence and ejaculatory dysfunction.No other details were provided to procept.Per manufacturer instructions for use, incontinence or overactive bladder and ejaculatory dysfunction are potential risks of the aquablation procedure.Procept is in the process of attempting to find out additional information on this event, including whether the patient underwent an aquablation procedure, which was unable to be determined with the initial information provided.
|
Three good faith efforts (gfes) were made to obtain additional information and it was not possible to confirm the user facility where the event occurred or whether this patient had undergone an aquablation procedure.The investigation consisted of a review of the information reported to procept, plus a review the device's labeling.The aquabeam robotic system instructions for use (ifu), ifu0104-00, rev.C, was reviewed and states the following: 4.3.Warnings: procedure as with any surgical urologic procedure, potential perioperative risks of the aquablation procedure include: incontinence or overactive bladder; sexual dysfunction, including ejaculatory and erectile dysfunction.A root cause for the reported event could not be determined.The aquabeam robotic system instructions for use list incontinence or overactive bladder and sexual dysfunction, including ejaculatory and erectile dysfunction as potential risks of the aquablation procedure.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
|